J Korean Med Sci.  2016 Mar;31(3):430-434. 10.3346/jkms.2016.31.3.430.

Interleukin-6 Receptor Polymorphisms Contribute to the Neurological Status of Korean Patients with Ischemic Stroke

• Kim DH
• Yoo SD
• Chon J
• Yun DH
• Kim HS
• Park HJ
• Kim SK
• Chung JH
• Kang JK
• Lee SA

• KMID: 2363505
• DOI: http://doi.org/10.3346/jkms.2016.31.3.430

Abstract

To investigate the contribution of the interleukin-6 receptor (IL-6R) gene single nucleotide polymorphisms (SNPs) to the neurological status of Korean patients with ischemic stroke (IS), two SNPs of the IL-6R gene (rs4845617, 5 UTR; rs2228144, Ala31Ala) were selected. IS patients were classified into clinical phenotypes according to two well-defined scores: the National Institutes of Health Stroke Survey (NIHSS) and the Modified Barthel Index scores. There were 121 IS patients and 291 control subjects. The SNP rs4845617 significantly contributed to the neurological status of patients with IS (P = 0.011 in codominant model 2, P = 0.006 in recessive model, and P = 0.008 in log-additive model). Allele frequencies of rs4845617 and rs2228144 demonstrated no significant difference in IS patients and controls. The AG and GG haplotypes differed between the NIHSS 1 (NIHSS scores < 6) group and the NIHSS 2 (NIHSS scores > or = 6) group in patients with IS (P = 0.014, P = 0.0024). These results suggest that rs4845617 of the IL-6R gene is associated with the neurologic status of Korean patients with IS.

Keyword

Interleukin 6-Interleukin 6 Receptor Fusion Protein, Recombinant; Brain Ischemia; Stroke; Neurological Manifestations; Polymorphism

MeSH Terms

Aged
Alleles
Asian Continental Ancestry Group/*genetics
Female
Gene Frequency
Genotype
Haplotypes
Humans
Logistic Models
Male
Middle Aged
Odds Ratio
Phenotype
Polymorphism, Single Nucleotide
Receptors, Interleukin-6/*genetics
Republic of Korea
Severity of Illness Index
Stroke/*genetics/pathology
Receptors, Interleukin-6

Reference

1. Andrawes WF, Bussy C, Belmin J. Prevention of cardiovascular events in elderly people. Drugs Aging. 2005; 22:859–876.

2. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G. Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des. 2008; 14:3574–3589.

3. Kang SY, Lee WI. Apolipoprotein e polymorphism in ischemic stroke patients with different pathogenetic origins. Korean J Lab Med. 2006; 26:210–216.

4. Kim MK, Kim JT, Choi SM, Lee SH, Park MS, Cho KH. Phosphodiesterase 4D gene and risk of noncardiogenic ischemic stroke in a Korean population. J Korean Med Sci. 2009; 24:307–310.

5. Kim NS, Ko MM, Cha MH, Oh SM, Bang OS. Age and sex dependent genetic effects of neuropeptide Y promoter polymorphism on susceptibility to ischemic stroke in Koreans. Clin Chim Acta. 2010; 411:1243–1247.

6. Kim OJ, Hong SP, Ahn JY, Hong SH, Hwang TS, Kim SO, Yoo W, Oh D, Kim NK. Influence of combined methionine synthase (MTR 2756A > G) and methylenetetrahydrofolate reductase (MTHFR 677C > T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke. Yonsei Med J. 2007; 48:201–209.

7. Kim Y, Kim JH, Nam YJ, Kong M, Kim YJ, Yu KH, Lee BC, Lee C. Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females. Neurosci Lett. 2006; 407:189–194.

8. Lee BC, Ahn SY, Doo HK, Yim SV, Lee HJ, Jin SY, Hong SJ, Lee SH, Kim SD, Seo JC, et al. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci Lett. 2004; 357:33–36.

9. Lee BC, Doo HK, Ahn SY, Byun SH, Kim SI, Park HK, Hong M, Ha E, Yim SV, Yin C, et al. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism is associated with the susceptibility to ischemic stroke in Taeeumin classified by Sasang medicine. Neurol Res. 2007; 29:Suppl 1. S32–7.

10. Park SA, Park BL, Park JH, Lee TK, Sung KB, Lee YK, Chang HS, Park CS, Shin HD. Association of polymorphisms in thromboxane A2 receptor and thromboxane A synthase 1 with cerebral infarction in a Korean population. BMB Rep. 2009; 42:200–205.

11. Um JY, Kim HM. Polymorphisms of RANTES and IL-4 genes in cerebral infarction. J Mol Neurosci. 2009; 37:1–5.

12. Meschia JF. Clinically translated ischemic stroke genomics. Stroke. 2004; 35:2735–2739.

13. Mallolas J, Hurtado O, Castellanos M, Blanco M, Sobrino T, Serena J, Vivancos J, Castillo J, Lizasoain I, Moro MA, et al. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med. 2006; 203:711–717.

14. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol. 2007; 6:149–161.

15. Yamada Y, Metoki N, Yoshida H, Satoh K, Kato K, Hibino T, Yokoi K, Watanabe S, Ichihara S, Aoyagi Y, et al. Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals. Stroke. 2008; 39:2211–2218.

16. Wang M, Song H, Jia J. Interleukin-6 receptor gene polymorphisms were associated with sporadic Alzheimer’s disease in Chinese Han. Brain Res. 2010; 1327:1–5.

17. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002; 347:1557–1565.

18. Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989; 46:660–662.

19. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996; 27:1817–1820.

20. Greisenegger S, Endler G, Haering D, Schillinger M, Lang W, Lalouschek W, Mannhalter C. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb Res. 2003; 110:181–186.

21. Wade DT. Measurement in neurological rehabilitation. Curr Opin Neurol Neurosurg. 1992; 5:682–686.

22. Park HK, Jo DJ. Polymorphisms of integrin, alpha 6 contribute to the development and neurologic symptoms of intracerebral hemorrhage in Korean population. J Korean Neurosurg Soc. 2011; 50:293–298.

23. Lewis CM. Genetic association studies: design, analysis and interpretation. Brief Bioinform. 2002; 3:146–153.

24. Matarin M, Singleton A, Hardy J, Meschia J. The genetics of ischaemic stroke. J Intern Med. 2010; 267:139–155.

25. Bevan S, Markus HS. Genetics of common polygenic ischaemic stroke: current understanding and future challenges. Stroke Res Treat. 2011; 2011:179061.

26. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain. 2000; 123:1784–1812.

27. Markus HS. Stroke genetics. Hum Mol Genet. 2011; 20:R124–31.

28. Gardener H, Beecham A, Cabral D, Yanuck D, Slifer S, Wang L, Blanton SH, Sacco RL, Juo SH, Rundek T. Carotid plaque and candidate genes related to inflammation and endothelial function in Hispanics from northern Manhattan. Stroke. 2011; 42:889–896.

29. Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004; 47:1403–1410.

30. Wolford JK, Colligan PB, Gruber JD, Bogardus C. Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab. 2003; 80:338–343.

31. Hamid YH, Urhammer SA, Jensen DP, Glümer C, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O. Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites. Diabetes. 2004; 53:3342–3345.

32. Wang H, Zhang Z, Chu W, Hale T, Cooper JJ, Elbein SC. Molecular screening and association analyses of the interleukin 6 receptor gene variants with type 2 diabetes, diabetic nephropathy, and insulin sensitivity. J Clin Endocrinol Metab. 2005; 90:1123–1129.

33. Esteve E, Villuendas G, Mallolas J, Vendrell J, López-Bermejo A, Rodríguez M, Recasens M, Ricart W, San Millán JL, Escobar-Morreale H, et al. Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin Endocrinol (Oxf). 2006; 65:88–91.

34. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, Buring JE, Kwiatkowski D, Cook NR, Miletich JP, Chasman DI. Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women’s Genome Health Study. Am J Hum Genet. 2008; 82:1185–1192.

35. Qi L, Rifai N, Hu FB. Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women. Diabetes. 2009; 58:275–278.

36. Chu NF, Lin FH, Chin HC, Hong YJ. Association between interleukin-6 receptor gene variations and atherosclerotic lipid profiles among young adolescents in Taiwan. Lipids Health Dis. 2011; 10:136.